BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 26040176)

  • 21. Vemurafenib: in unresectable or metastatic melanoma.
    Keating GM
    BioDrugs; 2012 Oct; 26(5):325-34. PubMed ID: 22946753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current therapy of carcinoma of the skin].
    Dummer R; Goldinger SM; Sailer E; French LE
    Ther Umsch; 2010 Sep; 67(9):447-52. PubMed ID: 20806173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curing Stage IV Melanoma: Where Have We Been and Where Are We?
    Chan PY; Corrie PG
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e438654. PubMed ID: 38669609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological characteristics, diagnosis and treatment of melanoma in Serbia--the Melanoma Focus Study.
    Kandolf-Sekulović L; Babović N; Jokić N; Nikolin B; Nikolić D; Janjić Z; Mijugković Z; Rajović M; Novaković M; Pejcić I; Kovaević P; Mihajlović D; Roganović T; Ferenc V; Nikolić J; Marinković M; Bizetić Z
    Vojnosanit Pregl; 2015 Apr; 72(4):312-6. PubMed ID: 26040176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
    Eggermont AM
    Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upcoming strategies for the treatment of metastatic melanoma.
    Spagnolo F; Queirolo P
    Arch Dermatol Res; 2012 Apr; 304(3):177-84. PubMed ID: 22350184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study and treatment of locally advanced melanoma].
    Moreno-Ramírez D; de la Cruz L; Ferrándiz L; Camacho FM
    Actas Dermosifiliogr; 2009 Nov; 100(9):767-79. PubMed ID: 19889298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current therapy for malignant melanoma.
    Legha SS
    Semin Oncol; 1989 Feb; 16(1 Suppl 1):34-44. PubMed ID: 2465575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease.
    Walsh P; Gibbs P; Gonzalez R
    J Am Acad Dermatol; 2000 Mar; 42(3):480-9. PubMed ID: 10688721
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.